Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Your body also needs energy to function and be productive when youre awake
Your body should be adapting to the medication, not fighting it harder each day
All handling must comply with applicable laboratory procedures, institutional protocols, and qualified research standards
Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)
When determining financial eligibility, states consider certain sources of income, such as: Social Security benefits Veterans benefits Pensions Salaries Interest/dividends However, income from assistance programs like food stamps or federal housing aid is typically not counted
US$ 28.41
US$ 20.98
US$ 20.89
